Story of the year: CimaVax-EGF, the first vaccine against lung cancer is Cuban

JSC: Jamaicans in Solidarity with Cuba

Reblogged from Lasantamambisa

The first therapeutic vaccine against lung cancer history has already been approved for marketing in Cuba. Now the experts evaluated the principle of implementing the function of promising drug in the treatment of other cancers.

lung cancer vaccineSpecialists Molecular Immunology Center of Havana took 25 years to develop the CimaVax-EGF vaccine. This preparation is an analog of EGF, epidermal growth factor, which is necessary for the growth and spread of cancer cells. In applying the drug, the body’s immune system attacks cells that produce EGF and thus tumor growth is significantly reduced.


The vaccine may not prevent the disease but improves the condition of critically ill patients. The Cimavax-EGF treatment is indicated for patients who have already undergone chemotherapy or radiation and are considered terminals without therapeutic alternative. Cimavax-EGF helps control tumor growth without associated toxicity and increases life expectancy and quality of life of patients with these tumors.

As explained in the…

View original post 163 more words


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: